These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2538905)

  • 41. Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
    Tella SH; Gallagher JC
    Expert Opin Pharmacother; 2013 Dec; 14(17):2407-20. PubMed ID: 24093499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen replacement therapy.
    Alcoff JM
    Am Fam Physician; 1982 Jun; 25(6):183-6. PubMed ID: 6282102
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of osteoporosis with antiresorptive drugs].
    Vestergaard P; Mosekilde L; Brixen K
    Ugeskr Laeger; 2005 Feb; 167(8):883-7. PubMed ID: 15789840
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
    Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
    Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.
    Baksu B; Baksu A; Göker N; Citak S
    Maturitas; 2009 Feb; 62(2):140-5. PubMed ID: 19179026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hormone substitution therapy. Side-effects and compliance of various therapeutic regimens].
    Perrone G; Barillaro F; Bazzoffi R; Capri O; Critelli C; Galoppi P; Grande S; Santoro G
    Minerva Ginecol; 1999 Mar; 51(3):53-8. PubMed ID: 10352534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone turnover-sex hormone-parathyroid hormone interrelationships in postmenopausal osteoporosis.
    Riggs B; Jowsey J; Kelly PJ; Arnaud CD
    Boll Soc Ital Biol Sper; 1973 Jul; 49(12):732-7. PubMed ID: 4364781
    [No Abstract]   [Full Text] [Related]  

  • 48. Ceruloplasmin serum level in post-menopausal women treated with oral estrogens administered at different times.
    Clemente C; Russo F; Caruso MG; Giangrande M; Fanizza G; Di Leo A
    Horm Metab Res; 1992 Apr; 24(4):191-3. PubMed ID: 1318259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women.
    Murkes D; Conner P; Leifland K; Tani E; Beliard A; Lundström E; Söderqvist G
    Fertil Steril; 2011 Mar; 95(3):1188-91. PubMed ID: 21067727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of equilin 3-monosulfate and other estrogens. Comparison by study of urinary gonadotropins in women.
    Howard RP; Keaty EC
    Arch Intern Med; 1971 Aug; 128(2):229-234. PubMed ID: 4327547
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
    Gleason CE; Carlsson CM; Johnson S; Atwood C; Asthana S
    Ann N Y Acad Sci; 2005 Jun; 1052():93-115. PubMed ID: 16024754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and biotransformation of estradiol valerate in ovariectomized women.
    Düsterberg B; Schmidt-Gollwitzer M; Hümpel M
    Horm Res; 1985; 21(3):145-54. PubMed ID: 2987096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What you should know about estrogens. Or the perils of Pauline.
    Landau RL
    JAMA; 1979 Jan; 241(1):47-51. PubMed ID: 214587
    [No Abstract]   [Full Text] [Related]  

  • 55. Postmenopausal bone mineral loss after treatment for malignant gynaecologic tumours.
    Lamke B; Björkholm E
    Acta Radiol Oncol; 1981; 20(2):109-11. PubMed ID: 6270962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone loss and hormone therapy.
    Rudavsky AZ
    Ann Intern Med; 1978 Jun; 88(6):846. PubMed ID: 208443
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum equilin and conjugated equine oestrogens.
    Woolever CA; Bhavnani BR
    Lancet; 1980 Mar; 1(8167):547-8. PubMed ID: 6102273
    [No Abstract]   [Full Text] [Related]  

  • 58. Postmenopausal osteoporosis.
    Gordan GS; Picchi J; Roof BS; Soika CV
    Am Fam Physician; 1973 Dec; 8(6):74-83. PubMed ID: 4357325
    [No Abstract]   [Full Text] [Related]  

  • 59. Skeletal effects of oestrogen and testosterone in postmenopausal women.
    BMJ; 1988 Sep; 297(6649):687-8. PubMed ID: 3179560
    [No Abstract]   [Full Text] [Related]  

  • 60. Metabolic fate of orally administered estradiol in swine.
    Bottoms GD; Coppoc GL; Monk E; Moore AB; Roesel OF; Regnier FE
    J Anim Sci; 1977 Sep; 45(3):674-85. PubMed ID: 198393
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.